Rolando Borges
Internal Medicine · Astoria, NYNPI 1457533234
Payments from drug & device makers
Across 331 payments — averaging $28.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Johnson & Johnson$1K
- AbbVie$1K
- Merz North America, Inc.$938
- Lilly USA, LLC$605
- Sanofi-aventis U.S. LLC$576
- plus $3K from 28 others
What the payments were for
- Food & beverage$9,382100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $1,309 |
| Johnson & Johnson | 29 | $1,307 |
| AbbVie(2 entities) | 73 | $1,216 |
| Merz North America, Inc. | 11 | $938 |
| Lilly USA, LLC | 31 | $605 |
| Sanofi-aventis U.S. LLC | 16 | $576 |
| Boehringer Ingelheim | 12 | $545 |
| Amarin Pharma, Inc. | 21 | $450 |
| Gilead | 14 | $334 |
| Novo Nordisk | 15 | $273 |
| Vifor Pharma, Inc. | 2 | $250 |
| Amgen | 6 | $225 |
| Pfizer | 11 | $209 |
| Merck | 7 | $128 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| Medtronic | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 6 | $94 |
| Astellas Pharma US Inc | 4 | $91 |
| Bausch Health US, LLC | 4 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $71 |
| Scilex Pharmaceuticals Inc. | 4 | $70 |
| Philips North America LLC | 3 | $60 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Sanofi Pasteur Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Irhythm Technologies, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Abbott | 1 | $16 |
| Strongbridge US Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,410 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 14 | $12 |
| Amlodipine Besylate | 12 | $2 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Astoria
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.